These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 16080523)

  • 21. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
    Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic significance of sex steroid and hypophyseal hormones in head and neck squamous cell carcinoma].
    Remenár E; Számel I; Budai B; Orosz Z; Gaudi I; Kásler M; Gundy S
    Magy Onkol; 2003; 47(2):155-9. PubMed ID: 12975662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
    Hoffmann TK; Sonkoly E; Homey B; Scheckenbach K; Gwosdz C; Bas M; Chaker A; Schirlau K; Whiteside TL
    Head Neck; 2007 May; 29(5):472-8. PubMed ID: 17111427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma.
    Homer JJ; Greenman J; Drevs J; Marme D; Stafford ND
    Head Neck; 2002 Aug; 24(8):773-8. PubMed ID: 12203803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.
    Deng YF; Chen P; Lin YZ; Le JZ; Wu XL; Yu MQ; Zhuang PY; Gao MH
    J Laryngol Otol; 2003 Mar; 117(3):190-4. PubMed ID: 12648374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
    Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
    Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
    Sinha UK; Mazhar K; Chinn SB; Dhillon VK; Liu L; Masood R; Rice DH; Gill PS
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of folate, homocysteine, and vitamin B12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia.
    Almadori G; Bussu F; Galli J; Cadoni G; Zappacosta B; Persichilli S; Minucci A; Giardina B; Maurizi M
    Cancer; 2005 Jan; 103(2):284-92. PubMed ID: 15593092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of IL-10 in patients with ovarian carcinoma.
    Mustea A; Könsgen D; Braicu EI; Pirvulescu C; Sun P; Sofroni D; Lichtenegger W; Sehouli J
    Anticancer Res; 2006; 26(2C):1715-8. PubMed ID: 16617566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma glutathione S-transferase P1-1 levels in patients with head and neck squamous cell carcinoma.
    Oude Ophuis MB; Mulder TP; Peters WH; Manni JJ
    Cancer; 1998 Jun; 82(12):2434-8. PubMed ID: 9635537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
    Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
    Anderhuber W; Steinschifter W; Gotschuli A; Schauenstein E; Schauenstein K
    Laryngorhinootologie; 1998 Oct; 77(10):564-8. PubMed ID: 9842520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma.
    Shinriki S; Ueda M; Ota K; Nakamura M; Kudo M; Ibusuki M; Kim J; Yoshitake Y; Fukuma D; Jono H; Kuratsu J; Shinohara M; Ando Y
    J Oral Pathol Med; 2010 Jan; 39(1):41-7. PubMed ID: 19453393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
    Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
    Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
    Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
    Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma.
    Li C; Zhao Y; Zhang W; Zhang W
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):81-9. PubMed ID: 21458322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of vascular endothelial growth factor in patients with head and neck cancer.
    Riedel F; Götte K; Schwalb J; Wirtz H; Bergler W; Hörmann K
    Eur Arch Otorhinolaryngol; 2000; 257(6):332-6. PubMed ID: 10993554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.